Americans are okay with gene-editing embryos to create healthier babies
The US public approves of gene-tailored babies but fears that the wealthy will use the technology first, leading to inequality.
The survey: The Pew Research Center asked 2,537 US adults how they felt about changing the genetic characteristics of babies using gene-editing tools.
Wide public support: Surprise. Seven out of 10 people said they think changing a baby’s genes is an appropriate use of technology, but only if it’s to treat or avoid a serious disease.
But only for healthy tots: When asked, only 20 percent thought making “more intelligent” humans would be acceptable. Most believed that using gene editing to increase intelligence would be taking things “too far.”
Top fear: Americans may be generally okay with genetically modified babies, but they still think negative results are more likely than positive ones. Survey respondents ranked inequality as their top worry. More than half think it’s “very likely” that gene-edited babies will only be available to the wealthy.
Deep Dive
Biotechnology and health
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
An AI-driven “factory of drugs” claims to have hit a big milestone
Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology
The quest to legitimize longevity medicine
Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.
There is a new most expensive drug in the world. Price tag: $4.25 million
But will the latest gene therapy suffer the curse of the costliest drug?
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.